[Intensity-modulated radiotherapy in the treatment of thyroid cancer].

Milan Vosmik, Karel Odrázka, Milan Zouhar, Jirí Petera, Josef Dvorák, Zdenek Zoul
{"title":"[Intensity-modulated radiotherapy in the treatment of thyroid cancer].","authors":"Milan Vosmik,&nbsp;Karel Odrázka,&nbsp;Milan Zouhar,&nbsp;Jirí Petera,&nbsp;Josef Dvorák,&nbsp;Zdenek Zoul","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The main problem of the conventional radiotherapy in postoperative or curative irradiation in thyroid cancer is to achieve a sufficient dose in the planning target volume with acceptable dose distribution homogeneity and at the same time not to exceed tolerance doses in the organs of risk. Our study presents the advantages of intensity-modulated radiotherapy over conventional radiotherapy on an example of dosimetric comparisons of isodose plans of three patients treated at our department. The intensity-modulated radiotherapy in thyroid cancer offers an improvement of dose homogeneity and better sparing of organs at risk (spinal cord and lungs). Furthermore, dose escalation is feasible in the whole initial planning target volume up to 60 Gy with a simultaneous sparing of healthy tissues and organs at risk.</p>","PeriodicalId":79548,"journal":{"name":"Acta medica (Hradec Kralove). Supplementum","volume":"47 2","pages":"151-4"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica (Hradec Kralove). Supplementum","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The main problem of the conventional radiotherapy in postoperative or curative irradiation in thyroid cancer is to achieve a sufficient dose in the planning target volume with acceptable dose distribution homogeneity and at the same time not to exceed tolerance doses in the organs of risk. Our study presents the advantages of intensity-modulated radiotherapy over conventional radiotherapy on an example of dosimetric comparisons of isodose plans of three patients treated at our department. The intensity-modulated radiotherapy in thyroid cancer offers an improvement of dose homogeneity and better sparing of organs at risk (spinal cord and lungs). Furthermore, dose escalation is feasible in the whole initial planning target volume up to 60 Gy with a simultaneous sparing of healthy tissues and organs at risk.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
调强放疗在甲状腺癌治疗中的应用
常规放疗在甲状腺癌术后或治疗性照射中的主要问题是在计划靶体积内达到足够剂量,剂量分布均匀性可接受,同时不超过危险器官的耐受剂量。我们的研究提出了调强放疗优于传统放疗的一个例子,对在我科治疗的三个病人的等剂量方案进行了剂量学比较。甲状腺癌的调强放疗改善了剂量均匀性,更好地保留了危险器官(脊髓和肺)。此外,在整个初始计划目标体积中,剂量递增至60戈瑞是可行的,同时保留处于危险中的健康组织和器官。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Immunoscintigraphy]. [Optimalization of methodical repertoire for laboratory diagnostic of autoimune diseases of the thyroid gland--aspiration cytology versus histology (cytodiagnostic accuracy)]. [Mitochondria and their role in cell metabolism]. [Significance of angiogenesis in malignant tumors]. [Mycoplasma hominis in female genital tract].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1